Kähkönen et al. [162] have demonstrated that 68Ga-labeled bombesin (68Ga-RM2; BAY86-7548) had high cancer-binding specificity and significantly higher uptake in prostate cancer than benign tissue. The gene discussed is GRP; the disease is prostate carcinoma.